You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Preclinical development of Novo29, a new antibiotic
SBC: NOVOBIOTIC PHARMACEUTICALS, LLC Topic: RAbstract The overall goal of this project is to conduct preclinical studies on Novoour newly discovered bactericidal compoundAs drug resistance continues to spreadnew classes of antibiotics are needed to combat infections by pathogens such as methicillin resistant Staphylococcus aureusMRSAand vancomycin resistant EnterococciVRENovois a novel class of peptidoglycan synthesis inhibitor with favorabl ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Discovery of Zika virus therapeutics using a replicon assay
SBC: MICROBIOTIX, INC. Topic: RABSTRACT The Zika virusZIKVis the cause of an explosive pandemic of infections across South and Central Americathe Caribbeanand the southeastern region of the United StatesZIKV is a flavivirusa family of small positive strand RNA viruses that includes Dengue virusDENVWest Nile virusWNVYellow fever virusYFVand hepatitis C virusHCVZIKV is transmitted to humans by mosquitoes of the Aedes genusFor the ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A Phase 2a Multicenter, Randomized, Vehicle-Controlled, Dose Escalating Study to Evaluate the Safety, Efficacy and Pharmacokinetics of CBT-001 Ophthalmic Solution in Pterygium Patients
SBC: CLOUDBREAK THERAPEUTICS LLC Topic: NPterygium is an ocular surface disease with abnormal fibrovascular growth on the cornea that affects aboutmillion individuals in the USLater stage disease impairs vision and the current standard of care is surgical removal of lesion tissueHoweverlesions recur in aboutof patients after surgeryBecause there is no approved drug to treat pterygiumwe propose to address this unmet medical need with a to ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Comprehensive but simple encoding of bioassays to accelerate translational drug discovery
SBC: COLLABORATIVE DRUG DISCOVERY, INC. Topic: 100PROJECT SUMMARY Collaborative Drug DiscoveryIncCDDproposes to extend its innovative software platformBioAssay ExpressBAEversionwhich helps biologists to quickly and easily encode their plain text biological assay protocols into formats suitable for computational processingIn PhaseBCDD will further enhance BAE so that it can markup a bioassay with a comprehensivedetailed set of annotations that com ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
FAST platform for same-shift, complete antibiotic menu antibiotic susceptibility testing
SBC: SeLux Diagnostics, Inc. Topic: RThe goal of this Phase I SBIR proposal is to demonstrate utility to all major pathogenic bacterial strains of SeLux s rapidlow costphenotypic antibiotic susceptibility testASTsystemfast AST or FASTUtilizing existing optical detectors and standard dried antibiotic microplatesand avoiding pitfalls of metabolic probesFAST will potentially transform therapy of infections by significantly accelerating ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Humanized Anti-Renalase Antibodies for Unresectable Melanoma
SBC: BESSOR PHARMA, LLC Topic: 102Project Summary AbstractThis project brings together an experiencedintegrated project team with complementary expertise to advance a new approach to treating melanomas that cannot cured by surgery and have spread in the bodyThe project attacks a new targetrenalasean endogenous protein that can function as a survival factorwhich becomes overexpressed in melanomaand plays a role in suppressing the b ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Interventions to Improve Reproductive Health among Adolescents
SBC: DFUSION INC. Topic: NICHDAlthoughyear olds are onlyof the U Ssexually active populationthey account for nearlyof themillion new cases of sexually transmitted infectionsSTIeach yearAlthough historically lowthe U Steen pregnancy rate continues to be one of the highest in the developed worldEvidence based prevention efforts can help avoid the costs and health consequences associated with STIs and unwanted teen pregnancy amon ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
CFI Pathogen Inactivation of Human Plasma Units
SBC: APHIOS CORPORATION Topic: NHLBIPROJECT SUMMARY The rapid spread of the Zika viruswhich can have a significant impact on neurological disorders in unborn fetuses and potentially adultsthe recent outbreak of the extremely virulent Ebola virusperiodic emergence of SARSrecurrent outbreaks of potentially pandemic strains of influenza such as H Nthe continuing epidemic of MERS and the worldwide AIDS epidemic have highlighted a persis ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Aerosol Delivery of Surfactant for ARDS
SBC: KAER BIOTHERAPEUTICS CORPORATION Topic: NHLBIAcute respiratory distress syndromeARDSafflicts aboutAmericans each yearThe pathology consists of rapid onset of respiratory symptoms including radiographic bilateral opacities and pulmonary edemaThe primary risk factors for the development of ARDS are pneumoniaaspirationmajor traumasepsisand inhalation injuryDespite the adoption of lung protective ventilationthe mortality rate remains aboutCommon ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Head mounted smartphone system for remote treatment of convergence insufficiency
SBC: EYEnexo LLC Topic: NEIPROJECT SUMMARYIn this projectwe propose to develop and demonstrate feasibility of a head mounted smartphone based application forin home training and remote monitoring of progress for patients with convergence insufficiencyCICI develops in anestimatedofschool agechildrenintheU Soverallandcausessymptomsofeyestrainblurredvisionand reduced concentrationresulting in significant educational disadvanta ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health